Drug:
Reaction: DRUG INEFFECTIVE
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25136838 |
US |
44 | 1 |
Diarrhoea, Drug ineffective, |
||||
SECUKINUMAB, |
||||
| 602 | 25136856 |
US |
76 | 2 |
Scar, Drug ineffective, Dry eye, |
||||
CYCLOSPORINE, CYCLOSPORINE, |
||||
| 603 | 25136901 |
US |
16 | 2 |
Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 604 | 25136954 |
US |
56 | 2 |
Plasma cell myeloma, Pain, Drug ineffective, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 605 | 25136998 |
HR |
49 | 2 |
Endoscopy abnormal, Drug ineffective, |
||||
MIRIKIZUMAB-MRKZ, |
||||
| 606 | 25137037 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 607 | 25137101 |
GB |
1 | |
Surgery, Drug ineffective, |
||||
UPADACITINIB, |
||||
| 608 | 25137106 |
US |
77 | 2 |
Wrist fracture, Urinary tract infection, Drug ineffective, Abdominal pain upper, Unevaluable event, |
||||
RISANKIZUMAB-RZAA, |
||||
| 609 | 25140769 |
47 | 2 | |
Drug ineffective, Dizziness, Brain fog, Cognitive disorder, Fatigue, Lethargy, Product substitution issue, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 610 | 25141176 |
72 | 2 | |
Infusion related reaction, Pain in jaw, Drug ineffective, Mastication disorder, Dysphagia, |
||||
ZOLEDRONIC ACID, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CARVEDILOL, APIXABAN, ERGOCALCIFEROL, MAGNESIUM, LUTEIN, |
||||
| 611 | 25141546 |
|||
Drug ineffective, |
||||
ARIPIPRAZOLE, |
||||
| 612 | 25141651 |
|||
Drug ineffective, |
||||
BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, |
||||
| 613 | 25141656 |
|||
Drug ineffective, Weight increased, Glycosylated haemoglobin increased, Blood glucose increased, Metabolic disorder, |
||||
OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 614 | 25141657 |
|||
Drug ineffective, Adverse drug reaction, |
||||
PHENTERMINE HYDROCHLORIDE, |
||||
| 615 | 25141662 |
|||
Drug ineffective, Metabolic disorder, Weight increased, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 616 | 25141663 |
|||
Drug ineffective, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 617 | 25126265 |
US |
31 | 2 |
Rheumatoid arthritis, Illness, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 618 | 25126296 |
US |
||
Drug ineffective, |
||||
ONABOTULINUMTOXINA, |
||||
| 619 | 25126317 |
US |
35 | 2 |
Drug ineffective, Product use in unapproved indication, |
||||
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, MAGNESIUM, ERGOCALCIFEROL, SERTRALINE HYDROCHLORIDE, |
||||
| 620 | 25126338 |
US |
14 | 1 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 621 | 25126413 |
US |
60 | 2 |
Pneumonia, Drug ineffective, Product dose omission issue, |
||||
ABATACEPT, |
||||
| 622 | 25126445 |
US |
99 | 2 |
Drug ineffective, Product substitution issue, |
||||
OXYBUTYNIN CHLORIDE, TOLTERODINE TARTRATE, TOLTERODINE, |
||||
| 623 | 25126456 |
US |
||
Drug ineffective, |
||||
TROSPIUM CHLORIDE, |
||||
| 624 | 25126457 |
ES |
||
Disease progression, Herpes simplex reactivation, Giardiasis, Malignant syphilis, Enteritis infectious, Drug ineffective, Intentional product use issue, Product use in unapproved indication, |
||||
RITUXIMAB, RITUXIMAB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, IBRUTINIB, IBRUTINIB, |
||||
| 625 | 25126472 |
US |
49 | 2 |
Drug ineffective, |
||||
GALCANEZUMAB-GNLM, |
||||
| 626 | 25126484 |
US |
75 | |
Incorrect dose administered, Insulin resistance, Drug ineffective, Blood glucose abnormal, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 627 | 25126495 |
GB |
||
Colitis ulcerative, Condition aggravated, Drug ineffective, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 628 | 25126514 |
US |
||
Drug ineffective, No adverse event, |
||||
OCRELIZUMAB, |
||||
| 629 | 25126570 |
US |
2 | |
Drug ineffective, |
||||
| 630 | 25126655 |
US |
1 | |
Drug ineffective, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 631 | 25126683 |
CA |
70 | 2 |
Condition aggravated, Drug ineffective, |
||||
DONEPEZIL HYDROCHLORIDE, GALANTAMINE, MEMANTINE, MEMANTINE HYDROCHLORIDE, RIVASTIGMINE, |
||||
| 632 | 25126720 |
JP |
||
Illness, Drug ineffective, |
||||
DARBEPOETIN ALFA, |
||||
| 633 | 25126736 |
US |
24 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Abortion spontaneous, Pregnancy with contraceptive device, Drug ineffective, Emotional distress, Depression, Anxiety, Device expulsion, |
||||
COPPER, |
||||
| 634 | 25126745 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 635 | 25126765 |
US |
48 | 2 |
Drug ineffective, Rash pruritic, Plastic surgery, Dermatitis atopic, Pigmentation disorder, Benign neoplasm of skin, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 636 | 25126772 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 637 | 25126776 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 638 | 25126777 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 639 | 25126783 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 640 | 25126794 |
US |
||
Drug ineffective, Therapeutic product effect delayed, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 641 | 25126799 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 642 | 25126801 |
US |
||
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 643 | 25126808 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, LEVOTHYROXINE, GUSELKUMAB, TOFACITINIB, |
||||
| 644 | 25126811 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 645 | 25126818 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 646 | 25126823 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 647 | 25126825 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 648 | 25126841 |
US |
63 | 2 |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 649 | 25126844 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 650 | 25126857 |
US |
67 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 651 | 25126859 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 652 | 25126863 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 653 | 25126865 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 654 | 25126873 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 655 | 25126877 |
US |
2 | |
Upper respiratory tract infection, Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 656 | 25126880 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 657 | 25126884 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE, |
||||
| 658 | 25126909 |
US |
79 | 1 |
Drug ineffective, Diet noncompliance, |
||||
EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
| 659 | 25126921 |
US |
1 | |
Increased appetite, Drug ineffective, |
||||
BIMEKIZUMAB, APREMILAST, |
||||
| 660 | 25126954 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, IXEKIZUMAB, |
||||
| 661 | 25126974 |
US |
2 | |
Injection site swelling, Infection, Drug ineffective, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 662 | 25127003 |
AU |
6 | 2 |
Brain fog, Fatigue, Drug ineffective, Drug intolerance, |
||||
CARBAMAZEPINE, GABAPENTIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 663 | 25127021 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 664 | 25127031 |
CA |
||
Condition aggravated, Drug ineffective, Suicidal ideation, Suicide attempt, Off label use, |
||||
LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, APIXABAN, BREXPIPRAZOLE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, GABAPENTIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEMBOREXANT, LORAZEPAM, MIRTAZAPINE, OLANZAPINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PRAMIPEXOLE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RISPERIDONE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VORTIOXETINE, ZOLPIDEM TARTRATE, PANTOPRAZOLE, |
||||
| 665 | 25127053 |
US |
2 | |
Atrial tachycardia, Psoriasis, Depression, Insomnia, Drug ineffective, |
||||
BIMEKIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMLODIPINE, METOPROLOL TARTRATE, METOPROLOL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, IRON, LORATADINE, LORATADINE ORAL, NITROFURANTOIN MACROCRYSTALS, NALTREXONE, |
||||
| 666 | 25127071 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 667 | 25127083 |
US |
38 | 2 |
Drug ineffective, |
||||
BIMEKIZUMAB, CEFPODOXIME PROXETIL, POLYETHYLENE GLYCOL 3350, FLUTICASONE PROPIONATE, ERGOCALCIFEROL, VITAMIN C, CEPHALEXIN, GLYCOPYRROLATE, SIMVASTATIN, ALBUTEROL SULFATE, GABAPENTIN, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, FAMOTIDINE, ONDANSETRON HYDROCHLORIDE, DEXLANSOPRAZOLE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, ALPRAZOLAM, SERTRALINE HYDROCHLORIDE, |
||||
| 668 | 25127120 |
US |
1 | |
Drug ineffective, Treatment noncompliance, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 669 | 25127126 |
US |
2 | |
Psoriasis, Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 670 | 25127142 |
US |
2 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 671 | 25127146 |
US |
2 | |
Candida infection, Psoriasis, Drug ineffective, |
||||
BIMEKIZUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, PROPRANOLOL HYDROCHLORIDE, LEVOTHYROXINE SODIUM, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 672 | 25127165 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 673 | 25127173 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 674 | 25127174 |
US |
1 | |
Drug ineffective, |
||||
BIMEKIZUMAB, |
||||
| 675 | 25127215 |
PK |
29 | 1 |
Disease progression, Drug ineffective, |
||||
POLATUZUMAB VEDOTIN, |
||||
| 676 | 25127230 |
US |
1 | |
Drug ineffective, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 677 | 25127234 |
US |
1 | |
Loss of personal independence in daily activities, Drug ineffective, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 678 | 25127244 |
US |
1 | |
Injection site pain, Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, ZOLPIDEM TARTRATE, ROSUVASTATIN CALCIUM, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 679 | 25127262 |
US |
2 | |
Drug ineffective, General physical health deterioration, |
||||
BIMEKIZUMAB, ALPRAZOLAM, SECUKINUMAB, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DICLOFENAC, DICLOFENAC SODIUM, PROPOFOL, |
||||
| 680 | 25127279 |
US |
29 | 2 |
Female sterilisation, Laparotomy, Endometrial cancer, Hysterectomy, Vaginal haemorrhage, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Pregnancy with contraceptive device, Drug ineffective, Emotional disorder, Heavy menstrual bleeding, Intentional device use issue, Off label use, |
||||
COPPER, |
||||
| 681 | 25127294 |
US |
2 | |
Reproductive complication associated with device, Abortion induced, Pregnancy with contraceptive device, Drug ineffective, Hormone level abnormal, Blood prolactin increased, Fatigue, Anxiety, Depression, Alopecia, Weight increased, Migraine, Muscular weakness, Breast tenderness, Device dislocation, Rash, Pain, Muscle spasms, Menstruation irregular, |
||||
COPPER, |
||||
| 682 | 25127296 |
US |
2 | |
Abortion induced, Pregnancy with contraceptive device, Drug ineffective, Complication of device removal, Device issue, |
||||
COPPER, |
||||
| 683 | 25127304 |
CA |
||
Skin lesion removal, Drug ineffective, |
||||
ADALIMUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, IRON, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, RIFAMPIN, |
||||
| 684 | 25127313 |
US |
1 | |
Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 685 | 25127334 |
PT |
||
Seizure, Drug ineffective, |
||||
ESLICARBAZEPINE ACETATE, PERAMPANEL, CLOBAZAM, |
||||
| 686 | 25127339 |
US |
||
Drug ineffective, Product quality issue, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 687 | 25127365 |
US |
||
Sepsis, Drug ineffective, |
||||
RAVULIZUMAB, |
||||
| 688 | 25127431 |
US |
||
Gait inability, Malignant neoplasm progression, Drug ineffective, |
||||
IVOSIDENIB, |
||||
| 689 | 25127496 |
US |
||
Drug ineffective, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, |
||||
| 690 | 25127504 |
US |
2 | |
Drug resistance, Drug ineffective, |
||||
ONABOTULINUMTOXINA, |
||||
| 691 | 25127520 |
CA |
64 | 2 |
Off label use, Condition aggravated, Drug ineffective, |
||||
DONEPEZIL HYDROCHLORIDE, GALANTAMINE, MEMANTINE, MEMANTINE HYDROCHLORIDE, RIVASTIGMINE, |
||||
| 692 | 25127521 |
CA |
2 | |
Caesarean section, Uterine haemorrhage, Dysstasia, Urticaria, Somnolence, Illness, Maternal exposure during pregnancy, Intentional dose omission, Drug ineffective, Maternal exposure during breast feeding, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 693 | 25127524 |
US |
42 | 2 |
Crohn^s disease, Device leakage, Drug ineffective, Incorrect dose administered, Device defective, Product storage error, Product dose omission issue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, LEVOTHYROXINE, |
||||
| 694 | 25127547 |
US |
63 | 2 |
Drug ineffective, |
||||
DEUTETRABENAZINE, |
||||
| 695 | 25127551 |
CA |
65 | 2 |
Condition aggravated, Off label use, Suicidal ideation, Suicide attempt, Drug ineffective, |
||||
APIXABAN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, GABAPENTIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LORAZEPAM, MIRTAZAPINE, OLANZAPINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PRAMIPEXOLE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RISPERIDONE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ZOLPIDEM TARTRATE, BREXPIPRAZOLE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE (XL), LEMBOREXANT, LURASIDONE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, VORTIOXETINE, PANTOPRAZOLE, |
||||
| 696 | 25127583 |
US |
89 | 1 |
Drug ineffective, |
||||
AVATROMBOPAG MALEATE, AVATROMBOPAG MALEATE, |
||||
| 697 | 25127595 |
US |
1 | |
Insomnia, Abnormal behaviour, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 698 | 25127620 |
CA |
46 | 1 |
Adverse drug reaction, Priapism, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 699 | 25127635 |
US |
32 | 1 |
Extrapyramidal disorder, Fall, Adverse event, Drug level above therapeutic, Reaction to excipient, Sedation, Therapy partial responder, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, BENZTROPINE, BENZTROPINE, BENZTROPINE, DIVALPROEX SODIUM, DIVALPROEX SODIUM, DIVALPROEX SODIUM, PERPHENAZINE, PERPHENAZINE, PERPHENAZINE, ZIPRASIDONE, ZIPRASIDONE, ZIPRASIDONE, AMLODIPINE, AMLODIPINE, AMLODIPINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, POLYETHYLENE GLYCOL, POLYETHYLENE GLYCOL, POLYETHYLENE GLYCOL, |
||||
| 700 | 25127640 |
AU |
10 | 2 |
Amnesia, Anal incontinence, Reading disorder, Speech disorder, Urinary incontinence, Disease recurrence, Drug ineffective, Off label use, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OLANZAPINE, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, AMANTADINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE, LITHIUM, LITHIUM BROMATUM, PROPRANOLOL HYDROCHLORIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), KETAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, RISPERIDONE, RITUXIMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28